Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001792044-25-000033
Filing Date
2025-08-07
Accepted
2025-08-07 16:05:13
Documents
101
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtrs-20250630.htm   iXBRL 10-Q 2511352
2 EX-31.1 ex_311xvtrsx20250630.htm EX-31.1 8477
3 EX-31.2 ex_312xvtrsx20250630.htm EX-31.2 8538
4 EX-32 ex_32xvtrsx20250630.htm EX-32 6246
  Complete submission text file 0001792044-25-000033.txt   13715895

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtrs-20250630.xsd EX-101.SCH 74371
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtrs-20250630_cal.xml EX-101.CAL 106244
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtrs-20250630_def.xml EX-101.DEF 451833
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtrs-20250630_lab.xml EX-101.LAB 905808
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtrs-20250630_pre.xml EX-101.PRE 704248
104 EXTRACTED XBRL INSTANCE DOCUMENT vtrs-20250630_htm.xml XML 2809476
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39695 | Film No.: 251193871
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)